• Aethlon Medical held its annual shareholder meeting on Oct. 1, 2026 in a virtual format.
• Shareholders backed an amendment to the 2020 Equity Incentive Plan, increasing the share reserve by 100,000; the change took effect Oct. 1, 2026.
• Director nominees were approved to serve until the next annual meeting.
• Shareholders ratified Haskell & White as independent registered public accounting firm for the fiscal year ending March 31, 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aethlon Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-007542), on October 01, 2026, and is solely responsible for the information contained therein.